Home > Insider Trading > Filing (0000899243-22-007418)

Filing Details

Accession Number:: 0000899243-22-007418
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-23 17:36:54
Reporting Period:: 2022-02-18

Accepted Time:: 2022-02-23 17:36:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235912	Cvrx Inc.	CVRX	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1523522	G. Kirk Nielsen	9201 W Broadway Ave #650 #650 Minneapolis MN 55445		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-18	26,659	$7.92	1,488,490	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2022-02-22	40,008	$7.94	1,528,498	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2022-02-23	38,200	$8.04	1,566,698	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.54 to $8.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.84 to $8.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4.